AARD
AARD
NASDAQ · Pharmaceuticals

Aardvark Therapeutics Inc

$5.38
-0.15 (-2.71%)
As of Sep 20, 10:35 PM ET ·
Analyst Consensus
Buy
18
Analysts
High
Coverage
Buy 11 61%
Hold 5 28%
Sell 2 11%
Price Target
Analyst Price Target +387.7% upside
Low Target $21.03
Average Target $26.24
High Target $41.18
Current Price $5.38
Current
$5.38
Target
$26.24
$21.03 $26.24 avg $41.18
Scenario Analysis
Bear Case
$21.03
290.9%
Low target
Base Case
$26.24
+387.7%
Avg target
Bull Case
$41.18
+665.4%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$17.94
-70.0% from high
52-Week Low
$3.35
+60.6% from low
Target vs 52W High
$26.24
+46.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +15.6%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +7.6%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +20.3%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +185.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -37.1%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +193.1%